Birmingham trust introduces new skin cancer drug
Two patients at Queen Elizabeth Hospital Birmingham were among the first in the country to start receiving a new anti-cancer drug within days of it being granted a licence.
Continue reading this article – simply subscribe below
Subscribe now for instant access to hsj.co.uk and our mobile site. Choose the package that suits you and get the weekly magazine, iPad app or both.
If you are a Health Service Journal subscriber please sign in with your email address and click submit: